N-Caffeoyltyramine arrests growth of U937 and Jurkat cells by inhibiting protein tyrosine phosphorylation and inducing caspase-3

Cancer Letters

Volumn 202, Issue 2, 2003, Pages 161-171

  Park, Jae B ^a   Schoene, Norberta ^a  

^a BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Capase 3; Cell death; Epidermal growth factor receptor; N Caffeoyltyramine; Tyrosine phosphorylation

Indexed keywords

AMINE; ANTINEOPLASTIC AGENT; CASPASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR; N CAFFYLTYRAMINE; N CINNAMYLTYRAMINE; N FERULYLTYRAMINE; N SINAPYLTYRAMINE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG POTENCY; DRUG RESEARCH; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHATIC LEUKEMIA; MONOCYTIC LEUKEMIA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN PHOSPHORYLATION; T CELL LEUKEMIA;

EID: 0344009736     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.08.010     Document Type: Article

References (45)

1. Heinrich M., Gibbons S. Ethnopharmacology in drug discovery: an analysis of its role and potential contribution. J. Pharm. Pharmacol. 53:2001;425-432.
2. Heinrich M. Ethnobotany and its role in drug development. Phytother. Res. 14:2000;479-488.
3. Sabar R., Kaye A.D., Frost E.A. Perioperative considerations for the patient taking herbal medicines. Heart Dis. 3:2001;87-96.
4. Macheix J.J., Fleuriet A., Billot J. Fruit Phenolics. 1990;CRC Press, Boca Raton, FL.
5. Havsteen B. Flavonoids: a class of natural products of high pharmacological potency. Biochem. Pharmacol. 32:1983;1141-1148.
6. Brandi M.L. Flavonoids: biochemical effects and therapeutic applications. Bone Miner. 19:1992;S3-14.
7. Harborne J.B. The flavonoids: advances in research since 1986. 1992;Chapman and Hall, New York.
8. Park J.B., Schoene N. Synthesis and characterization of N-coumaroyltyramine as a potent phytochemical which arrests human transformed cells via inhibiting protein tyrosine kinases. BBRC. 292:2002;1104-1110.
9. Albericio F., Carpino L.A. Coupling reagents and activation. Methods Enzymol. 289:1997;104-126.
10. Grankvist K., Lernmark A., Taljedal I.B. Alloxan cytotoxicity in vitro: microscope photometric analyses of trypan blue uptake by pancreatic islet cells in suspension. Biochem. J. 162:1977;19-24.
11. Jordan J.P., Hand C.M., Markowitz R.S., Black P. Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay. J. Neurooncol. 14:1992;19-35.
12. Imbert-Marcille B.M., Coste-Burel M., Robillard N., Foucaud-Gamen J., Billaudel S., Drouet E. Sequential use of paraformaldehyde and methanol as optimal conditions for the direct quantification of ZEBRA and Rta antigens by flow cytometry. Clin. Diag. Lab. Immunol. 7:2000;206-211.
13. Far D.F., Peyron J.F., Imbert V., Rossi B. Immunofluorescent quantification of tyrosine phosphorylation of cellular proteins in whole cells by flow cytometry. Cytometry. 15:1994;327-334.
14. Park J.W., Choi Y.J., Jang M.A., Lee Y.S., Jun D.Y., Suh S.I., Baek W.K., Suh M.H., Jin I.N., Kwon T.K. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells. Cancer Lett. 163:2001;43-49.
15. Wajant H. The Fas signaling pathway: more than a paradigm. Science. 296:2002;1635-1636.
16. Elledge S.J. Cell cycle checkpoints: preventing identity crisis. Science. 274:1996;1664-1672.
17. Evan G., Littlewood T. A matter of life and cell death. Science. 281:1998;1317-1322.
18. Kunduzova O.R., Bianchi P., Pizzinat N., Escourrou G., Seguelas M.H., Parini A., Cambon C. Regulation of JNK/ERK activation, cell apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-reperfusion. FASEB J. 16:2002;112911-112931.
19. Mendelsohn A.R., Hamer J.D., Wang Z.B., Brent R. Cyclin D3 activates Caspase 2, connecting cell proliferation with cell death. Proc. Natl. Acad. Sci. USA. 99:2002;6871-6876.
20. Umeda T., Kouchi Z., Kawahara H., Tomioka S., Sasagawa N., Maeda T., Sorimachi H., Ishiura S., Suzuki K. Limited proteolysis of filamin is catalyzed by caspase-3 in U937 and Jurkat cells. J. Biochem. (Tokyo). 130:2001;535-542.
21. O'Callaghan Y.C., Woods J.A., O'Brien N.M. Comparative study of the cytotoxicity and apoptosis-inducing potential of commonly occurring oxysterols. Cell Biol. Toxicol. 17:2001;127-137.
22. Laird A.D., Christensen J.G., Li G., Carver J., Smith K., Xin X., Moss K.G., Louie S.G., Mendel D.B., Cherrington J.M. SU6668 inhibits Flk-1/KDR and PDGFRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice. FASEB J. 16:2002;681-690.
23. Lui V.W., Grandis J.R. EGFR-mediated cell cycle regulation. Anticancer Res. 22:2002;1-11.
24. Blake R.A., Broome M.A., Liu X., Wu J., Gishizky M., Sun L., Courtneidge S.A. SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. 20:2000;9018-9027.
25. Kalidas M., Kantarjian H., Talpaz M. Chronic myelogenous leukemia. JAMA. 286:2001;895-898.
26. Park J.B. Flavonoids are potential inhibitors of glucose uptake in U937 cells. BBRC. 260:1999;568-574.
27. Park J.B., Levine M. Intracellular accumulation of ascorbic acid is inhibited by flavonoids via blocking both dehydroascorbic acid and ascorbic acid uptake in the transformed cells. J. Nutr. 130:2000;1297-1302.
28. Park J.B. Inhibition of Glucose and Dehydroascorbic Acid Uptake by Resveratrol in Human Transfomed Myeolocytic Cells. J. Nat. Prod. 64:2001;381-384.
29. Song J., Kwon O., Chen S., Daruwala R., Eck P., Park J.B., Levine M. Flavonoid inhibition of sodium-dependent vitamin C transporter 1(SVCT1) and glucose transporter isoform 2 (Glut2), intestinal transporters for vitamin C and glucose. J. Biol. Chem. 277:2002;15252-15260.
30. Mans D.R., da Rocha A.B., Schwartsmann G. Anti-cancer drug discovery and development in Brazil: targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds. Oncologist. 5:2000;185-198.
31. Barker A.J., Gibson K.H., Grundy W., Godfrey A.A., Barlow J.J., Healy M.P., Woodburn J.R., Ashton S.E., Curry B.J., Scarlett L., Henthorn L., Richards L. Studies leading to the identification of ZD1839 (Iressa): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg. Med. Chem. Lett. 11:2001;1911-1914.
32. Heinrich M., Rimpler H., Barrera N.A. Indigenous phytotherapy of gastrointestinal disorders in a lowland Mixe community (Oaxaca Mexico): ethnopharmacologic evaluation. J. Ethnopharmacol. 36:1992;63-80.
33. Fry S.C. Phenolic components of the primary cell wall. Feruloylated disaccharides of D-galactose and L-arabinose from spinach polysaccharide. Biochem. J. 203:1982;493-504.
34. Schmidt A., Grimm R., Schmidt J., Scheel D., Strack D., Rosahl S. Cloning and expression of a potato cDNA encoding hydroxycinnamoyl-CoA:tyramine N-(hydroxycinnamoyl)transferase. J. Biol. Chem. 274:1996;4273-4280.
35. Lo S.C., Nicholson R.L. Reduction of light-induced anthocyanin accumulation in inoculated sorghum mesocotyls. Implications for a compensatory role in the defense response. Plant Physiol. 116:1998;979-989.
36. Back K., Jang S.M., Lee B.C., Schmidt A., Strack D., Kim K.M. Cloning and characterization of a hydroxycinnamoyl-CoA:tyramine N-(hydroxycinnamoyl) transferase induced in response to UV-C and wounding from Capsicum annuum. Plant Cell Physiol. 42:2001;475-481.
37. Verpoorte R., Memelink J. Engineering secondary metabolite production in plants. Curr. Opin. Biotechnol. 13:2002;181-187.
38. Hirai K.I., Koyama J., Pan J., Simamura E., Shimada H., Yamori T., Sato S., Tagahara K., Tsuruo T. Furanonaphthoquinone analogs possessing preferential antitumor activity compared to normal cells. Cancer Detect. Prev. 23:1999;539-550.
39. Mitra A., Mayer M.J., Mellon F.A., Michael A.J., Narbad A., Parr A.J., Waldron K.W., Walton N.J. 4-Hydroxycinnamoyl-CoA hydratase/lyase, an enzyme of phenylpropanoid cleavage from Pseudomonas, causes formation of C(6)-C(1) acid and alcohol glucose conjugates when expressed in hairy roots of Datura stramonium, L. Planta. 215:2002;79-89.
40. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.
41. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
42. Wessely O., Mellitzer G., von Lindern M., Levitzki A., Gazit A., Ischenko I., Hayman M.J., Beug H. Distinct roles of the receptor tyrosine kinases c-ErbB and c-Kit in regulating the balance between erythroid cell proliferation and differentiation. Cell Growth Differ. 8:1997;481-493.
43. Nardini M., Leonardi F., Scaccini C., Virgili F. Modulation of ceramide-induced NF-kappaB binding activity and apoptotic response by caffeic acid in U937 cells: comparison with other antioxidants. Free Radic. Biol. Med. 30:2001;722-733.
44. Pai R., Ohta M., Itani R.M., Sarfeh I.J., Tarnawski A.S. Induction of mitogen-activated protein kinase signal transduction pathway during gastric ulcer healing in rats. Gastroenterology. 114:1998;706-713.
45. Seger R., Biener Y., Feinstein R., Hanoch T., Gazit A., Zick Y. Differential activation of mitogen-activated protein kinase and S6 kinase signaling pathways by 12-O-tetradecanoylphorbol-13-acetate (TPA) and insulin. Evidence for involvement of a TPA-stimulated protein-tyrosine kinase. J. Biol. Chem. 270:1995;28325-28330.